The 2017 NIH Intramural Research Festival was an amazing scientific potpourri of innovative research and new biotechnology as well as an opportunity to showcase the work of our trainees and fellows. Yet attendance was at best modest for most of the sessions. What should we do to encourage all of our scientific staff to participate more fully?
In October 2017, Norman E. “Ned” Sharpless became the 15th director of the National Cancer Institute; NIH partnered with 11 leading pharmaceutical companies to accelerate the development of new cancer immunotherapy strategies.
Meet your recently tenured colleagues: Nihal Altan-Bonnet (NHLBI); Sonja M. Best (NIAID) [pictured]; Melissa C. Friesen (NCI-DCEG); Gretchen L. Gierach (NCI-DCEG); and Hong Xu (NHLBI).
Read about how the NIH Clinical Center is providing one of the largest publicly available chest X-ray datasets to the scientific community; the ZATT protein is reversing DNA damage caused by cancer treatment; Gulf-spill oil dispersants are associated with health symptoms in cleanup workers; NCI researchers solved the DNA Linking-Number Paradox; and more.
Buck Whitetail, the acting director of the National Institute for Cervinae, Hydropotinae, and other Deer, pauses briefly before meeting with the NIH director about the controversial deer-neutering program.
Lectures, deadlines, contests, Benefits Fair, Leave Bank, and more. Pictured: Steve Rosenberg (NCI) who will be giving the Chen Lecture on November 17, on “Cells as Anti-Cancer Drugs: Entering Mainstream Oncology.”
